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{Voiland School of Chemical Engineering and Bioengineering, Washington State University, Pullman, WashingtonABSTRACT Eg5 is a homotetrameric kinesin-5 motor protein that generates outward force on the overlapping, antiparallel
microtubules (MTs) of the mitotic spindle. Upon binding an MT, an Eg5 dimer releases one ADP molecule, undergoes a slow
(~0.5 s1) isomerization, and finally releases a second ADP, adopting a tightly MT-bound, nucleotide-free (APO) conformation.
This conformation precedes ATP binding and stepping. Here, we use mutagenesis, steady-state and pre-steady-state kinetics,
motility assays, and electron paramagnetic resonance spectroscopy to examine Eg5 monomers and dimers as they bind MTs
and initiate stepping. We demonstrate that a critical element of Eg5, loop 5 (L5), accelerates ADP release during the initial
MT-binding event. Furthermore, our electron paramagnetic resonance data show that L5 mediates the slow isomerization by
preventing Eg5 dimer heads from binding the MT until they release ADP. Finally, we find that Eg5 having a seven-residue dele-
tion within L5 can still hydrolyze ATP and move along MTs, suggesting that L5 is not required to accelerate subsequent steps of
the motor along the MT. Taken together, these properties of L5 explain the kinetic effects of L5-directed inhibition on Eg5 activity
and may direct further interventions targeting Eg5 activity.INTRODUCTIONThe homotetrameric, human kinesin-5 motor Eg5 is re-
quired for mitosis. An Eg5 tetramer attaches a pair of motor
domains to each of two overlapping, antiparallel microtu-
bules (MTs) of the mitotic spindle and generates an
outward-directed force. Because Eg5 plays a critical role
in setting up the mitotic spindle, its mechanism and regula-
tion are of considerable interest in cancer therapy. Two
classes of agents—allosteric and ATP-competitive Eg5
inhibitors—are being developed as antimitotics (1,2), and
have already proved to be useful reagents for cell biological
studies (3,4).
Like the two heads of the well-studied kinesin-1 motor,
the two heads of an Eg5 dimer appear to be enzymatically
coupled on MTs. However, the mechanochemical properties
of truncated Eg5 dimers are markedly different from those
of kinesin-1 dimers. Eg5 dimers in solution appear to have
two distinct ADP affinities (0.6 mM and 3.3 mM), in nearly
stoichiometric amounts (5). After the first Eg5 head ejects
ADP and binds to the MT, the Eg5 dimer undergoes a
slow (0.5 s1) isomerization before the second head ejects
ADP (6). The resulting state, with both heads nucleotide-
free (APO/APO), does not generally occur in the enzymatic
cycle of the kinesin-1 dimer (7). From Eg5’s APO/APOSubmitted July 13, 2011, and accepted for publication October 13, 2011.
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0006-3495/11/12/2760/10 $2.00conformation, the rear head binds to and hydrolyzes ATP,
which releases it from the MT and allows the dimer to
take a forward step. After this initial step, the Eg5 dimer
subsequently takes a total of 8–10 fast processive steps
along the MT, coupled to ATPase activity, at a rate of
10–12 s1 before dissociating (5,8).
Eg5’s low processivity stands in stark contrast to
kinesin-1’s ability to take 100 steps or more per processive
run (9). During Eg5’s fast stepping phase, the rate-limiting
step is ATP hydrolysis (5), whereas for kinesin-1 it is phos-
phate release (7,10). The lag that precedes the second ADP
release (referred to here as ‘‘the slow isomerization’’) is
particularly puzzling, as it only occurs upon initial contact
with the MTand not during subsequent steps of a processive
run. Furthermore, this feature of Eg5’s enzymatic cycle
appears to be completely distinct from other kinesins,
suggesting that a slow transition into an APO/APO confor-
mation may tailor Eg5 to its specific mitotic MT cross-link-
ing function (8).
Some of Eg5’s unique properties result from structural
coupling mechanisms within the motor domain that are
specific to the kinesin-5 family. The loop 5 (L5) element
in the Eg5 head is exceptionally long relative to other
kinesin families. L5 is critical for the binding of several
allosteric inhibitors of Eg5 (11–13). Electron paramagnetic
resonance (EPR) and fluorescence polarization studies on
Eg5 monomers have determined that L5 is structurally
coupled to both the nucleotide site and the neck-linker
element that initiates forward motility in kinesin-family
motors (14–16), possibly using its conformational flexibility
to contact the nearby Switch I motif (14,17). It is unknowndoi: 10.1016/j.bpj.2011.10.032
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tions in Eg5 dimers or tetramers. In this study, we examine
the role of L5 in coordinating the two heads of the Eg5
dimer. We compare wild-type Eg5 monomers and dimers
with mutants having a deletion within L5, using kinetics,
EPR spectroscopy, and motility assays.MATERIALS AND METHODS
Cloning, expression, and protein purification
Details on cloning are in the Supporting Material. All constructs were
verified by DNA sequencing. Growth, expression, and purification of all
Eg5-367 proteins in Escherichia coli were as described previously
(8,15,18,19). The same protocols were followed for Eg5-513 proteins.
Experiments were performed in HEPES buffer (10 mM HEPES, pH 6.8,
2 mM magnesium chloride, 1 mM EGTA, 100 mM sodium chloride,
150 mM sucrose, 0.02% (v/v) TWEEN 20) at 25C, unless otherwise
specified.Steady-state ATPase measurements
A malachite green assay was utilized to monitor the ATPase activities of
the wild-type and DL5 motors as described in Leonard et al. (20). After
each time course was completed, the reaction was transferred to a 96-
well microplate for endpoint absorbance reading at 650 nm using an xMark
spectrophotometer (Bio-Rad, Hercules, CA). A phosphate standard curve,
spanning from 3 to 96 mM KH2PO4, was generated for each experiment
and read in parallel.Pre-steady-state kinetic assays
The kinetics of MANT-ADP release were measured using an SF-2004
stopped-flow instrument (KinTek, Austin, TX) as described previously
(6,21). Nucleotide was first removed from Eg5 by adding 10 mM EDTA
directly to the protein (chelating the Mg2þ that allows kinesin motors to
bind nucleotide), concentrating in a spin concentrator 10-fold, and diluting
in EDTA buffer (10 mM HEPES, pH 6.8, 10 mM EDTA, 1 mM EGTA,
100 mM NaCl, 150 mM sucrose). This process was repeated 3–4 times
before buffer-exchanging the protein into HEPES buffer using a P-30
(Bio-Rad, Hercules, CA) spin column. Experiments were performed by
equilibrating Eg5 (1 mM) with a stoichiometric quantity of MANT-ADP
racemate. This Eg5,MANT-ADP complex was rapidly mixed with
10 mM MTs plus 1 mM MgATP, and MANT fluorescence was monitored
over time (Ex, 356 nm; Em, >400 nm).Protein labeling and EPR spectroscopy
Detailed methods for spin labeling, sample preparation, EPR spectroscopy,
and data analysis are in the Supporting Material, and are similar to those
used in Larson et al. (15,22,23).FIGURE 1 Eg5 head showing probe and L5 positions. Eg5 head (gray)
with the neck-linker in its docked conformation (PDB: 3hqd; blue). The
bound ADP, a6 helix, and neck-linker portions of a perpendicular neck-
linker structure are superimposed (PDB: 1ii6; neck-linker in black). Ribose
oxygens on ADP are marked, and V365C is indicated in spacefill on the
neck-linker. L5 (tan) is in sausage-type representation, except for the seven
deleted residues (red) in the DL5 motor protein (TWEEDPL). All fluores-
cent and spin probe structures have been reported elsewhere (6,15,21).Motility assays
Motility assays were performed essentially as described in Larson et al.
(24), with details provided in the Supporting Material. For motile velocity
measurements, 30-min time-lapse movies were analyzed using ImageJ soft-
ware (http://rsbweb.nih.gov/ij/). The position of the end of each MT was
evaluated for sixty 30-s time increments. Time-averaged velocities were
measured from at least 10 different MTs on each of 2–5 different slides.RESULTS
Motor proteins and probes used to determine
kinetic and structural properties of the Eg5 dimer
To determine how the two heads of the Eg5 dimer coordi-
nate with each other, we performed pre-steady-state and
steady-state kinetics, motility assays, and EPR spectroscopy
on both monomeric (Eg5-367) and dimeric Eg5 (Eg5-513)
motor proteins. These proteins have been kinetically and
thermodynamically characterized by our group and others
(5,6,13–15,25). We also constructed mutants having a dele-
tion of seven residues within L5 (amino acids 126–132:
TWEEDPL, referred to as ‘‘DL5’’ here).
For EPR spectroscopy, spin probes were either attached
to the ribose oxygens of ADP (similar to MANT-ADP) to
sample the nucleotide pocket of wild-type Eg5 or they
were covalently attached to a specifically introduced
cysteine in the neck-linker of cys-light Eg5; this motor
has been described previously and has wild-type activity
(15,26). Fig. 1 shows the location of the labeled sites and
probes used in this study.Both wild-type and DL5 mutants of Eg5 proteins
are active and have rate-limiting ADP release in
the absence of MTs
We first performed ATPase and ADP release experiments
on both Eg5-367 and Eg5-367 DL5 in the absence of MTsBiophysical Journal 101(11) 2760–2769
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on monomer activity. Fluorescence enhancement was
observed upon MANT-ADP addition to both proteins, con-
sistent with MANT-ADP binding to the nucleotide pocket
(5). The fluorescence enhancement observed upon MANT-
ADP binding to Eg5-367 DL5 was significantly greater
than that observed for wild-type (10-fold enhancement
versus threefold; data not shown). This difference may
reflect a higher MANT-ADP affinity for Eg5-367 DL5 or
structural differences in the nucleotide pocket of wild-type
Eg5 versus DL5 mutant.
The basal ATPase rate (0.25 s1) and basal ADP release
rate (0.27 s1) measured for Eg5-367 were similar, consis-
tent with rate-limiting ADP release. These values are also
consistent with those previously reported in Cochran and
Gilbert (27). The basal ATPase and ADP release rates for
Eg5-367 DL5 were substantially slower (0.03 s1 and
0.005 s1, respectively). The faster ATPase activity relative
to ADP release may be due to difficulties measuring such
slow rates in a stopped-flow device, or it may reflect a
slightly higher affinity for MANT-ADP than unmodified
ADP; in either case, ADP release appears to be rate-
limiting. Thus, the DL5 mutant binds MANT-ADP, is active,
and has rate-limiting ADP release in the absence of MTs.
However, the DL5 mutation decreases both the basal
ATPase and ADP release rates of Eg5-367 by at least an
order of magnitude (Fig. 2 A, Table 1).FIGURE 2 Summary of MANT-ADP release transients for the different
Eg5 motors. (A) The kinetics of MANT-ADP release for Eg5-367 wild-
type and DL5 were measured by first equilibrating Eg5 with MANT-ADP
(1:1) followed by rapid mixing of the Eg5,MANT-ADP complex with
MTs plus excess MgATP to effectively prevent rebinding of MANT-ADP
nucleotide to the Eg5 active site. A control transient (squares) with no
Eg5 added to the MANT-ADP provides the fluorescence intensity of
MANT-ADP in solution. Final concentrations in the wild-type (circles)
and DL5 (triangles) experiments are: 1.25 mM Eg5, 1 mM MANT-ADP,
10 mMMTs, 20 mM Taxol, 500 mMATP. Data were fit to a single exponen-
tial rate of 42.3 5 9.9 s1 for wild-type Eg5-367 and 0.008 5 0.002 for
Eg5-367DL5. (B) Transients for basal MANT-ADP release from Eg5-367
wild-type (circles) and DL5 (triangles), as well as MT-stimulated
MANT-ADP release from Eg5-367 DL5 (rhombi) are shown on a longer
time domain. Concentrations of reactants are the same as in panel A.
Data were fit to a single exponential rate of 0.27 5 0.02 s1 for wild-
type Eg5-367 and 0.005 5 0.002 s1 for Eg5-367 DL5. (C) Transient
showing MT-stimulated MANT-ADP release for Eg5-513 DL5. Concentra-
tions of reactants are the same as in panel A. Data were fit to a two-expo-
nential rates of 0.15 5 0.01 s1 and 0.005 5 0.001 s1. In panels A and
B, transients have been normalized for comparative purposes.The DL5 mutation severely inhibits
MT-stimulation of initial ADP release but
modestly slows ATPase activity and motility
To test the effects of L5 on Eg5’s initial MT-stimulated ADP
release event, we measured the rates of MT-stimulated
MANT-ADP release for Eg5-367 and Eg5-367 DL5, in
the presence of 10 mM MTs. Eg5-367 released ADP at
42.3 s1, comparable with previous observations (26). In
striking contrast, Eg5-367 DL5 released ADP ~5000-fold
slower, at 0.008 s1. MTs stimulate Eg5-367 ADP release
>200-fold, but do not significantly stimulate Eg5-367
DL5 ADP release. Previous work on allosteric inhibitors
of Eg5 that bind to L5 demonstrated that these drug treat-
ments allow the Eg5 head to bind to MTs while remaining
tightly bound to ADP, and that MT stimulation of ADP
release is inhibited (18,21,28). This is similar to our findings
here with Eg5-367 DL5 (Table 1, Fig. 2 B).
After the initial ADP release event, the steady-state
ATPase activity of Eg5-367 DL5 at 10 mM MTs is
only twofold slower than wild-type Eg5-367 (3.7 s1 vs.
6.3 s1; see Table 1), and roughly 450-fold faster than the
initial rate of MT-stimulated ADP release under the same
conditions (3.7 s1 vs. 0.008 s1). This high steady-state
ATPase activity relative to initial ADP release suggests that
the Eg5-367 DL5 monomer, unlike wild-type Eg5-367,
hydrolyzes several molecules of ATP per MT encounter,Biophysical Journal 101(11) 2760–2769with subsequent rounds of ATP hydrolysis occurring more
quickly than the initial ADP release event (29). Our exper-
iments reveal the same phenomenon with dimeric Eg5-513
DL5, which undergoes MT-stimulated ADP release at a
TABLE 1 ADP release, ATPase, and motility rates of Eg5
motor proteins
Enzymatic activity
Eg5-367 Eg5-367 DL5 Eg5-513 DL5
Basal ADP release (s1) 0.275 0.02 0.0055 0.002 —
Basal ATPase (s1 site1) 0.255 0.02 0.035 0.004 —
MT-stim ADP
release (s1)




6.255 0.21 3.695 0.44 1.005 0.03
Motility rate (nm/s)
Eg5-367 Eg5-367 DL5 Eg5-513 Eg5-513 DL5
20.55 2.8 12.15 1.1 32.95 4.2 2.85 0.5
Basal and MT-stimulated ADP release and ATPase rates, as well as sliding
velocities are experimentally determined averages5 the standard deviation
(n¼ 2–9 for individual reactions). Transients for ADP release rate measure-
ments are shown in Fig. 2. Microtubule sliding motility rate measurements
are depicted in Movie S1, Movie S2, Movie S3, and Movie S4 in the Sup-
porting Material.
L5 Coordinates Eg5 Dimers 2763maximal rate of 0.15 s1, but has a steady-state ATPase rate
of 1.0 s1 (Table 1, Fig. 2 C).
To determine whether the ATPase activity of the DL5
proteins could drive MT sliding, we performed sliding
motility assays (Table 1, and seeMovie S1,Movie S2,Movie
S3, and Movie S4 in the Supporting Material). In multiple
fields of view on several separate slides, the vast majority
ofMTsmoved steadily. There was an approximately twofold
reduction in the motile velocity of Eg5-367 DL5 relative to
Eg5-367 (12.1 nm/s vs. 20.5 nm/s), which mirrors the
twofold reduction in ATPase activity described above. We
also observed the MT sliding velocities of the Eg5-513
proteins. Wild-type Eg5-513 slides MTs at a rate of 33 nm/s,
which is reasonably consistent with several previous reports
(8,30,31). The motile velocity of Eg5-513 DL5 was reduced
to 2.8 nm/s. This velocity is sevenfold less than that of wild-
type Eg5-367, which is again comparable to their sixfold
difference in ATPase activity (6.3 s1 vs. 1.0 s1).
These results together indicate that despite their extremely
slow basal and MT-stimulated ADP release rates, the DL5
mutants are properly folded and active. As the ATPase
activity and MT sliding velocities of both Eg5-367 DL5
and Eg5-513 DL5 motors exhibit substantially less severe
defects than their initial MT-stimulated ADP release rates
(5000-fold for the Eg5-367 proteins), we conclude that the
DL5 mutation has its most profound effect on Eg5’s initial,
MT-stimulated ADP release event. Once Eg5 has bound to
the MT and released its initial ADP, the DL5 mutant motors
can still efficiently couple ATPase activity to motility, albeit
at a slower rate than wild-type motors.EPR spectroscopy on Eg5 dimers
Two questions emerge from the above data: First, do Eg5-
367 and Eg5-513 have different kinetics because of aninteraction between the two heads of an Eg5 dimer, or
because of differences in monomer versus dimer neck-linker
dynamics? Second, what, structurally, occurs in the slow
isomerization step, and how is L5 involved? We approached
these questions using EPR spectroscopy. EPR spectra are
exquisitely sensitive to the environment of the EPR probe,
and the EPR timescale is fast compared to most protein
conformational changes (15,32,33). Thus, an interaction
between the two heads of an Eg5 dimer could alter either
the components of an EPR spectrum, their relative abun-
dance, or both, and these changes are readily quantifiable
by spectral deconvolution (23).The Eg5 head interconverts between high
and low ADP affinity states in solution
We performed EPR spectroscopy on labeled Eg5 dimers in
solution to detect head-head interactions or head-head
communication. Fig. 3 A shows spectra of 20,30-SLADP
bound to both Eg5-367 and Eg5-513. As described previ-
ously, Eg5-367 displays two spectral components (labeled
C1 and C2 in Fig. 3 A) whereas Eg5-367 DL5 has only
the C1 inner component (15). The Eg5-513 and Eg5-513
DL5 dimer spectra shown here have exactly the same
components in the same relative amounts as Eg5-367 and
Eg5-367 DL5, respectively. These data suggest that dimer-
ization does not alter the abundance of the structural states
observed for 20,30-SLADP in the Eg5 nucleotide pocket,
either directly or allosterically. Furthermore, for Eg5-513
bound to 20,30-SLADP, the same C1 and C2 components
are present, with the same relative amounts of spin probe
in each component, at 0.7 mM, 7 mM, and saturating 20,30-
SLADP. This suggests that each nucleotide binding site
in Eg5-513 transitions between the conformations corre-
sponding to the C1 and C2 components quickly, relative
to the bound-state lifetime of the 20,30-SLADP probe (see
Fig. S6).
To probe the relative populations of 20,30-SLADP probes
in the different conformational states observed by EPR, we
performed spectral deconvolutions on the wild-type
Eg5-367 and Eg5-513 spectra shown in Fig. 3 A. Deconvo-
lutions were performed using a linear least-squares method
with known basis spectra as inputs (15,23). Both Eg5-367
and Eg5-513 spectra could be deconvolved into three
components: free probe in solution, the inner C1 component
(which resembles the DL5 spectrum), and the L5-depen-
dent, outer C2 component. Approximately 70% of 20,30-
SLADP probes in both Eg5-367 and Eg5-513 spectra were
found in the inner, C1 component, whereas 30% were found
in the outer, C2 component. Krzysiak et al. (5) similarly
found that ~60% of Eg5-513 heads partition into a high
ADP affinity state, whereas the remaining 40% are in a
low ADP affinity state. Meanwhile, the DL5 mutation
and/or L5-targeted inhibition have been found to increase
ADP affinity (18,34). Therefore, the inner, C1 componentBiophysical Journal 101(11) 2760–2769
FIGURE 3 EPR on the nucleotide pocket of Eg5-513 in solution and bound to MTs. (A) EPR spectra of wild-type (black) and DL5 (red) Eg5-367 and Eg5-
513 bound to 20,30-SLADP in solution. Spectra of wild-type Eg5 reveal two components corresponding to protein-bound probe—an inner mobile component
(C1) and an outer, nearly immobilized component (C2). Spectra are scaled so that C1 components have similar magnitudes, and protein-bound components
are expanded (at left) for comparison. C2 is not observed for the Eg5-513 DL5 mutant, as reported previously for Eg5-367 (15). (B) Comparison of MT-bound
Eg5-513 nucleotide probe spectra with monomer spectra. (Black) Spectra of MT-bound pellets of Eg5-513; (red) Eg5-367 solution spectra; and (blue) Eg5-
367 MT-bound pellet spectra. All spectra are scaled so that the outer, Eg5-bound components have similar magnitudes. Eg5-bound components are expanded
(at left) for comparison. (i) Wild-type Eg5 bound to 20,30-SLADP. (ii) DL5 mutants bound to 20,30-SLADP. (iii) STLC-treated, wild-type Eg5 bound to 20,30-
SLADP. (iv) Wild-type Eg5 bound to 20,30-SLADP,AlFx. (C) Splittings of EPR spectral components, reported in milliTesla (mT). Splittings are generally
accurate to within50.2 mT; see Larson et al. (15) for details. (Short dashed line) No C2 component is present for the sample. For splittings (labeled with
double asterisks), see Fig. S6 in the Supporting Material; note that although the splittings determined by the peak of the spectral components are not signif-
icantly different, the MT-bound spectrum is broadened.
2764 Waitzman et al.seen in our wild-type and DL5 EPR spectra may correspond
to a highADPaffinity state, whereas the outer, C2 component
may correspond to a low ADP affinity state that is accessible
towild-type, but notDL5motors. BothEg5-367 andEg5-513
can access both conformations, and they both access the
L5-dependent conformation ~30% of the time.EPR spectra of the nucleotide site and neck-liner
of Eg5-367 and Eg5-513 are identical
We next performed EPR using an MSL probe site-specifi-
cally attached to position V365 within the neck-linker to
test whether potential interactions between the two heads
establish an asymmetry between the two heads in solution.
Fig. S7 shows the spectra of MSL bound to Eg5-513
in the ADP and APO nucleotide states in solution. Notably,
the same spectral components are seen in both states, in theBiophysical Journal 101(11) 2760–2769same relative amounts, and these are similar to what has
been reported previously for Eg5-367 (15). Thus, we
observe no structural effects of dimerization in either the
nucleotide pocket or the neck-linker.L5 prevents Eg5 dimer heads from
simultaneously binding ADP and the MT
We proceeded to examine how the heads of Eg5-513 are
coupled to each other whereas the motor is bound to MTs
using spin-labeled Eg5 motors pelleted with MTs. Robust
EPR signals from pellet samples verified that Eg5-513 and
Eg5-513 DL5 motor proteins were bound to MTs in all
experimental conditions, but these proteins may have either
one or both heads bound.
The spectrum of 20,30-SLADP bound to Eg5-367 on MTs
shows a distinctly different set of components from the
L5 Coordinates Eg5 Dimers 2765solution spectrum, as described previously (Fig. 3 B (i), blue
versus red spectrum) (15). In general, EPR spectra of 20,30-
SLADP bound to kinesin motors, including Eg5, are broad-
ened upon binding the MT due to a movement of Switch I
toward the nucleotide pocket (32,33,35). For Eg5-367, this
appears as an outward shift of the C1 component. This
broadening effect occurs for 20,30-SLADP bound to Eg5-
367, Eg5-367 DL5, STLC-treated Eg5-367, and for the
Eg5-367,ADP,AlFx complex upon MT binding (Fig. 3 C)
(15). Thus, the Eg5-367 EPR spectra can serve as signatures
for MT-bound versus unbound Eg5 heads.
Fig. 3 B (i) shows an overlay of Eg5-513 bound to
20,30-SLADP and MTs (black) with spectra of Eg5-367
bound to 20,30-SLADP in solution (red) and bound to MTs
(blue). The spectral components of 20,30-SLADP bound to
Eg5-513 within these pellets were more similar to those
observed for Eg5-367 in solution than to those of Eg5-367
bound to MTs. The majority of 20,30-SLADP probes are
therefore likely to be bound to MT-unbound Eg5-513 heads.
As the concentrations of MTs in these pelleted samples is
60 mM before centrifugation and in the range of several
hundred micromolar afterward, these experiments are not
suited for determining the affinities of ADP-bound heads
for MTs. Rather, these experiments represent an extreme
point: even at several hundred micromolar MTs, we do
not observe a significant fraction of 20,30-SLADP-bound
Eg5 heads bound to MTs. Thus, the vast majority of Eg5-
513 heads are either MT-bound or 20,30-SLADP-bound,
but not bound to both. Notably, this binary split between
ADP-binding and MT-binding is an emergent property of
Eg5-513 that is not present in Eg5-367 (21).
Our previous work showed that the DL5 mutation did
not affect the EPR spectrum of 20,30-SLADP on MT-bound
Eg5-367 (Fig. 3 B (i and ii)) (15). The EPR spectrum of
20,30-SLADP bound to Eg5-513 DL5 on MTs is very similar
to that of 20,30-SLADP bound to either Eg5-367 or Eg5-367
DL5 on MTs (Fig. 3 B (ii), black versus blue spectrum). This
spectrum appears shifted outward slightly relative to the
Eg5-367 DL5 solution spectrum (Fig. 3 B (ii), black versus
red spectrum; see also Fig. 3 C, and Fig. S8 in the Support-
ing Material). Similarly, STLC treatment of Eg5-367
yielded a single spectral component for 20,30-SLADP, and
this component clearly shifted outward when the monomer
bound to MTs (Fig. 3 B (iii), red versus blue spectrum) (15).
The spectrum of Eg5-513 in the presence of STLC resem-
bles the MT-bound spectrum of Eg5-367 in the presence
of STLC. We interpret these data to indicate that disruption
of L5, either by the DL5 mutation or by STLC treatment,
enables Eg5-513 to bind to both 20,30-SLADP and MTs.
In our previous work, we observed that 20,30-SLADP,
AlFx bound to Eg5-367 in solution yields the same two
spectral components as 20,30-SLADP (red spectra, Fig. 3 B
(i and iv)) (15). On MTs, however, 20,30-SLADP,AlFx
induces pronounced spectral broadening of both compo-
nents. Interestingly, the spectrum of 20,30-SLADP,AlFxbound to wild-type Eg5-513 resembles the MT-bound
Eg5-367 spectrum, consistent with dimer heads containing
ADP,AlFx being bound to MTs. Thus, the inability of an
Eg5-513 head to bind both ADP and the MT does not apply
to the ADP,AlFx state.
In summary, Eg5 dimers differ from monomers in that a
head of an Eg5 dimer that is bound to ADP does not bind
to MTs, and vice versa (Fig. 3 B (i)). In a preparation of
ADP-Eg5-513 bound to MTs, some dimers will adopt a
conformation having an APO MT-bound head and an
ADP-bound free head, but many dimers may, in fact,
discharge both ADPs.Eg5 dimers bind to MTs with one neck-linker
docked and one undocked
We then turned our attention to how dimerization affects the
conformation of the neck-linker element. In previous work,
our lab used MSL attached to position V365 of Eg5-367 to
report on the neck-linker conformational state (Fig. 1 and
Fig. 4 A). These spectra showed two components in both
the ADP and APO states on MTs, with a significant shift
to the more immobilized component in the APO state rela-
tive to ADP (15). Based on previous studies of kinesin-1 and
Eg5, the immobilized component has been interpreted to
report the docked neck-linker conformation that positions
a partner head over its binding site, one tubulin dimer
toward the plus-end of the MT. The mobile component
has been interpreted to represent the perpendicular confor-
mation of the neck-linker that allows the forward head
of a pair of heads to assume an extended length and reach
its binding site (15,16,36,37).
Spectra of MSL attached to V365C on Eg5-513 bound
to MTs revealed the same immobilized component with a
splitting of ~6.5 milliTesla (mT) as observed for Eg5-367
(Fig. 4, A and C). Spectra taken in the presence of ADP,
in the APO state, and in the presence of ADP,AlFx are virtu-
ally identical. All of these spectra show roughly half of
probes in the mobile component and half in the immobilized
component (Fig. 4 C and see Fig. S9). As discussed above,
our preparation of ADP-Eg5 dimers bound to MTs may
have discharged one or both ADPs, and we suspect that a
significant fraction of these motors may be bound to the
MT in an APO/APO state.
Several lines of evidence suggest that the vast majority of
Eg5-513 dimers in the APO/APO and ADP,AlFx-bound
states have both heads bound to the MT. Our data above
using 2030-SLADP,AlFx indicated that the vast majority of
Eg5-513 heads in that sample are MT-bound. The APO state
of an Eg5 head, like the ADP,AlFx state, has high MT
affinity, and EPR spectra of MSL bound to the neck-linker
reveal the same spectral components in the same relative
amounts as for ADP,AlFx-bound Eg5.
Unlike wild-type Eg5-513, Eg5-513 DL5 can bind to
20,30-SLADP and MTs simultaneously (Fig. 3 B (ii)). AsBiophysical Journal 101(11) 2760–2769
FIGURE 4 EPR spectra of MSL bound to the neck-linker of Eg5 bound
to MTs. (A) Wild-type Eg5-367 undergoes a significant conformational
restriction from ADP (black)/APO (blue), and remains immobilized in
ADP,AlFx (purple). In contrast, Eg5-367 DL5 has a highly immobilized
neck-linker throughout its nucleotide cycle (15). (B) Both Eg5-513 and
Eg5-513 DL5 are ~50% immobilized in all three nucleotide states, suggest-
ing that one neck-linker is docked and one is undocked. (C) Splittings of
EPR spectral components in mT and spectral deconvolution results.
2766 Waitzman et al.shown in Fig. 4 B, the MSL-labeled Eg5-513 DL5 spectra
are nearly identical to those taken of Eg5-513 without the
DL5 mutation, as ~50% of probes are in the more immobi-
lized component and 50% are in the more mobile com-
ponent (Fig. 4 C and see Fig. S9). These data imply a
conformation for Eg5-513 DL5 like that of wild-type Eg5-
513, with one head having a docked neck-linker and the
other with its neck-linker undocked. Taken together, our
data suggest that Eg5 dimers initiate movement by binding
to MTs with both heads; regardless of DL5 mutation status,
one neck-linker of Eg5-513 must enter an undocked con-
formation. From this conformation, wild-type Eg5 begins
stepping rapidly, whereas the DL5 mutant is limited by its
slower rate of MT-stimulated ADP release.Biophysical Journal 101(11) 2760–2769DISCUSSION
Based on our results, we have three major conclusions
regarding the Eg5 dimer mechanochemical cycle: First,
major structural changes resulting from an interaction of
the two heads of an Eg5 dimer are unlikely to occur in solu-
tion. Second, L5 induces a conformation of the head in an
Eg5 dimer that cannot simultaneously bind to ADP and
MTs. This finding provides a structural basis for the slow
isomerization step. Third, Eg5 heads release ADP more
quickly from the ADP,Pi state that occurs after the APO/
APO conformation on MTs than from the ADP state in solu-
tion. A model based on these findings is shown in Fig. 5; the
data supporting these conclusions are discussed below.The nucleotide pockets and neck-linkers
of dimeric Eg5 appear to be structurally
equivalent in solution
The structural environments of the nucleotide pocket and
the neck-linker as observed by EPR provide a sensitive
readout of many aspects of motor activity, including the
nucleotide state, MT-binding, neck-linker conformation,
and even the concentrations of various buffer components
(15,32,33,36). Nonetheless, the EPR spectra of 20,30-
SLADP bound to the nucleotide pocket of Eg5-513 were
indistinguishable from those of Eg5-367. In both cases,
70% of probes were found in a higher mobility component
and 30% in a lower mobility component. Similar spectra
taken with DL5 motor proteins or STLC treatment, which
result in increased ADP affinity, yielded only the higher
mobility component. Taken together, these data suggest
that each wild-type Eg5 head, regardless of dimerization
status, occupies a high ADP affinity state ~70% of the
time and a low ADP affinity state ~30% of the time.
A more detailed discussion of these results is given in the
Supporting Material, including a comparison to the
MANT-ADP titrations described in Krzysiak et al. (5).
As the monomer and dimer spectra are indistinguishable,
we conclude that dimerization is unlikely to exert a signifi-
cant effect on nucleotide site and/or neck-linker structure for
Eg5 in solution. Our data are not definitive in ruling out
interactions between the two Eg5 heads. However, they do
argue that the coordination between the nucleotide pockets
and neck-linker elements that enables an Eg5 dimer to
initiate a processive run is established upon binding to the
MT rather than in solution before binding to the MT.L5 induces a conformation of Eg5 that cannot
simultaneously bind ADP and MTs
Our kinetic data show that L5 substantially increases the
initial rate of ADP release of Eg5 monomers and dimers,
both in solution and on MTs (Table 1). Meanwhile, our
structural data using EPR indicate that Eg5-513 heads that
FIGURE 5 Model of Eg5 dimer mechanochemical cycle; bound nucleotides indicated as follows. (Red) Eg5 heads in solution. (Cyan) Eg5 heads MT-
bound. (Purple) Eg5 heads undergoing rapid detachment from a rearward binding site followed by rebinding to a forward binding site. In solution, the
two Eg5 dimer heads are equivalent. The initial MT-stimulated ADP release event is rapid (Step 1). After this step, the second ADP-bound Eg5-513
head cannot bind to MTs, whereas the APO state favors a docked neck-linker conformation on MTs. As a result, the transition into the APO/APO confor-
mation, with one docked and one undocked neck-linker, is very slow (Step 2). Subsequent ATP binding to the rear head is rapid (Step 3). After hydrolysis
(Step 4), the rear head, which may be bound to ADP,Pi or may have just released phosphate, is able to rebind in front of the APO head (Step 5) much more
rapidly than in Step 2. This ADP,Pi (or ADP) state may prime the detaching head for fast MT rebinding, enabling subsequent steps on the MT to occur much
faster than the initial slow isomerization step, particularly for DL5 proteins (cycle to Step 3). The DL5 mutation slows Step 1 and Step 2 several hundredfold,
but affects subsequent steps only ~10-fold. These data suggest that the action of L5 during the initiation steps of the Eg5 cycle (Step 1 and Step 2) may mimic
the ADP,Pi (or ADP) state (Step 5) that accelerates Eg5 activity during subsequent steps.
L5 Coordinates Eg5 Dimers 2767are bound to 20,30-SLADP do not bind to MTs. This ‘‘either/
or’’ binding is L5- and nucleotide-dependent, as both
Eg5-513 DL5 heads and STLC-treated heads bound to
20,30-SLADP bind to MTs, as do Eg5-513 heads bound to
20,30-SLADP,AlFx (Fig. 3). Based on all of these data, we
propose that L5 induces a conformation of the Eg5 head
in solution that cannot simultaneously bind to ADP and
MTs. Our kinetic data show that this L5-dependent confor-
mation of the Eg5 head accelerates MT-stimulated ADP
release.The structural basis of the slow isomerization
step of Eg5-513 is the low MT-stimulation
of ADP release from the second head
An Eg5-513 dimer releases one ADP molecule upon MT
binding, then undergoes an ~0.5 s1 isomerization step
before releasing its second ADP (5). Our results show that
even at very high nucleotide and MT concentrations, Eg5
dimer heads do not bind to both ADP and MTs at the
same time (Fig. 3). Additionally, wild-type, but not DL5
nor STLC-treated Eg5 heads, can access a weak ADP
affinity conformation in solution (Fig. 3). Previous results
suggest that APO-Eg5 is stable in solution (27). These
results together suggest that L5 may weaken both the
ADP and MT affinity of Eg5 dimer heads.
To span the 8-nm distance between adjacent MT binding
sites, the heads of the Eg5-513 dimer must bind one in front
of the other, with the rear head having a docked neck-linker
whereas the forward head has an undocked neck-linker. Our
EPR data support this mode of binding: in all nucleotide
states we observe approximately half of probes in the
mobile spectral component and half in the more immobi-
lized component (Fig. 4). Thus, the slow isomerization
step results from a conformational conundrum for the two
Eg5 heads. As APO Eg5-367 monomers favor the dockedneck-linker conformation (15,16), the two heads are both
energetically predisposed to dock their neck-linkers upon
releasing ADP and binding the MT. However, structurally,
one of the two heads must bind to the MT with its neck-
linker undocked. We conclude that after the first head of
the Eg5-513 dimer binds MTs and releases ADP, the slow
isomerization step is a concerted transition from a state in
which the second head is ADP-bound and MT-unbound to
one in which the dimer has two APO, MT-bound heads
with a forward, undocked neck-linker and a rear, docked
neck-linker.The rate of ADP release differs between initial
and subsequent steps of Eg5
The Eg5-513 ATPase rate has been estimated to increase
~20-fold after the slow isomerization step, to 10.7 s1 (5).
Our results with both Eg5-367 DL5 and Eg5-513 DL5
show that the steady-state ATPase activity of these proteins
is much faster than initial MT-stimulated ADP release
(Table 1; 3.69 s1 vs. 0.008 s1 for Eg5-367; 1.00 s1 vs.
0.15 s1 for Eg5-513). These data suggest that Eg5 heads
have accelerated ADP release in subsequent steps relative
to the first, initiation step, and these subsequent steps do not
depend heavily on L5. There must be a structural difference
between the initial MT-stimulated ADP release event, which
is accelerated by L5, and subsequent, much faster ADP
release events that take place after ATP binding and hydro-
lysis on theMT,which can be stimulated independently ofL5.
We propose that L5 induces a conformation of the nucle-
otide pocket of the ADP-bound Eg5 head in solution with
weak MT affinity and weak ADP affinity. This L5-ADP
conformation can stimulate initial ADP release by the first
Eg5 head because the first head is conformationally free
to dock its neck-linker upon releasing ADP (Fig. 5, Step
1), but cannot accelerate MT-binding by the second headBiophysical Journal 101(11) 2760–2769
2768 Waitzman et al.(Fig. 5, Step 2). After both heads have bound to the MT
in their APO states, ATP binds to the nucleotide pocket
of the rear head and is hydrolyzed (Fig. 5, Step 3 and
Step 4). The rear head transitions into a weakly MT-bound
ADP,Pi conformation that does not require L5. This allows
the front (APO) head to dock its neck-linker and detach the
rear ADP,Pi head from the MT (Fig. 5, Step 5). If Pi release
by the rear head is followed by sufficiently rapid rebinding
of that head to the forward binding site with the neck-linker
undocked, it can bypass the L5-ADP conformation and the
slow isomerization step. In subsequent steps, MT-stimulated
ADP release is rapid and largely L5-independent, due to this
Pi-dependent mechanism (Fig. 5, Step 5/Step 3).
The kinetic and structural features of Eg5-367 DL5 and
Eg5-513 DL5 are consistent with the above model. Both
proteins have severely reduced rates of initial ADP release.
However, subsequent hydrolysis events are relatively unhin-
dered by the DL5 mutation, reduced only 2–7-fold. Eg5-513
DL5 can bind to the MT with both heads without releasing
ADP (Fig. 3 B (ii)), then undergo multiple rounds of ATP
hydrolysis without releasing from the MT (Table 1). Both
Eg5-367 DL5 and Eg5-513 DL5 proteins perform remark-
ably well in motility assays, where other motors may stim-
ulate MT detachment (Table 1, and see Fig. S5).
Previous data support a model in which L5 affects the Eg5
nucleotide pocket conformation (14,17,25,38). While we
hypothesize that L5 competes with Pi, allowing the ADP-
bound motor domain in solution to assume an ADP,Pi-
like state that can rapidly discharge ADP, other models
are tenable. Regardless, we have established that there is
a substantial difference between Eg5’s L5-dependent, initial
MT-stimulated ADP release event and subsequent ADP
release events, which are accelerated independently of L5.
Additionally, wild-type Eg5 must have a MT dissociation
pathway that is not available to the DL5 mutant, as the
wild-type motor hydrolyzes fewer ATPs per encounter
with the MT. Future work will be needed to determine the
structural mechanisms that underlie these observations.Inhibitors of Eg5 that target L5 and the nucleotide
pocket target different aspects of motor activity,
and would likely have synergistic effects
Our results and previous kinetic characterizations by other
groups suggest that allosteric inhibitors of Eg5 like STLC
or ispinesib function much like the DL5 mutation
(18,21,28). These agents should drastically slow initial
ADP release, but have relatively minor effects on Eg5
motility once the motors engage MTs. Our motility assays
of the DL5 mutants indicate that the MT-sliding ability of
allosterically inhibited Eg5 motors may increase when
many motors are coupled together. As the mitotic spindle
couples the motility of multiple Eg5 tetramers, it is not clear
whether mitosis would be effectively inhibited in the pres-
ence of many kinetically slowed but not arrested Eg5motors.Biophysical Journal 101(11) 2760–2769Intriguingly, the L5-targeted allosteric inhibitors have faced
significant setbacks in clinical trials, largely due to insuffi-
cient inhibition of cancer cell division in vivo (39).
ATP-competitive inhibitors halt Eg5’s activity by a dif-
ferent mechanism. These inhibitors bind to APO, MT-bound
heads, locking them tightly to MTs (2,3). This action would
be expected to prevent detachment of the rear head of an
Eg5 dimer, effectively preventing motors from driving
MT sliding. The independent structural mechanisms of
ATP-competitive and allosteric inhibitors suggest that a
combination of these two types of agents could provide
synergistic effects on motor activity in both cell biological
and clinical studies.SUPPORTING MATERIAL
Supporting methods, discussions, four movies, and five figures are available
at http://www.biophysj.org/biophysj/supplemental/S0006-3495(11)01253-7.
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